Company Lookup
Download Demo

Market News

This Month News

This Month News

send to a friend by email

Jerusalem Pharmaceutical earns a pretax profit of JD2.63 million in 2010


Jerusalem Pharmaceutical disclosed the preliminary annual financial statements for the year 2010, which indicated pretax profit of JD 2.63 million compared to JD 1.65  million in 2009.

 To view Sahem’s report regarding the company’s financial results, click on the following link:

Sahem Fact Sheet 2010


Medium liquidity with the start of routine anticipation for the 9M 2017 financial data disclosures

A transaction on the stocks of PALTEL raises the liquidity levels this week



Sahem Trading & Investments Company - PEX Member and licensed by PCMA
© All Rights Reserved 2013